PMHNP Lifespan II Practice Final Exam: 30 Questions with Correct Solutions and Rationales – Latest 2026 Edition

This comprehensive practice final examination resource for PMHNP Lifespan II features 30 high-yield questions with correct answers and detailed evidence-based rationales, covering essential topics in psychiatric-mental health nurse practitioner practice across the lifespan. The content addresses critical areas including psychopharmacology in special populations, personality disorders, emergency psychiatry, ethical and legal issues, perinatal psychiatry, informed consent, scope of practice, neurobiology, child and adolescent psychiatry, geriatric psychopharmacology, and substance use disorders. Key topics include the importance of baseline electrocardiogram (EKG) before initiating citalopram in older adults due to QTc prolongation risk; the distinction between personality disorders (enduring, pervasive, ego-syntonic patterns) and episodic Axis I conditions; borderline personality disorder criteria including unstable relationships, impulsivity, fear of abandonment, and chronic emptiness; management of psychiatric emergencies with prioritization of safety and consideration of chemical or physical restraint when necessary; the insufficiency of “no-harm contracts” in suicide risk management and the necessity of comprehensive risk assessment and safety planning; selective serotonin reuptake inhibitors (SSRIs) as first-line antidepressants in pregnancy with shared decision-making balancing fetal risks against risks of untreated maternal illness; the Tarasoff duty to protect requiring notification of identifiable third parties and law enforcement when a patient makes a credible threat of harm; elements of valid informed consent including competence, adequate information, and voluntary agreement; ethical obligation to practice within scope of licensure and refer when care exceeds qualifications; serotonergic system as primary target of first-line antidepressants; anticholinergic side effects of tricyclic antidepressants (TCAs) including dry mouth, constipation, and blurred vision; paraphilic disorders requiring treatment only when associated with distress, impairment, or harm to others; medication-induced cognitive impairment as a reversible cause of cognitive decline in older adults requiring thorough medication review before assuming dementia; risks of abrupt psychotropic discontinuation during pregnancy versus maternal relapse risks; beneficence as the ethical principle supported by accurate patient documentation; lithium safety education emphasizing consistent fluid and salt intake and recognition of toxicity signs (tremor, ataxia, slurred speech); FDA-approved atypical antipsychotics for adolescent schizophrenia (aripiprazole, olanzapine, quetiapine, risperidone, paliperidone); Freudian oral stage fixation associated with passive and dependent personality traits; paranoid personality disorder characterized by pervasive distrust without frank psychosis; pharmacokinetic and pharmacodynamic changes in geriatric patients including reduced metabolism and excretion requiring “start low, go slow” approach; justice as the ethical principle of fair distribution of healthcare resources; Munchausen syndrome by proxy (factitious disorder imposed on another) as a form of child abuse requiring mandatory reporting; older Caucasian men as the demographic group with highest suicide rates in the United States; lamotrigine-associated Stevens-Johnson syndrome requiring slow dose titration and patient education; NONPF core competencies for nurse practitioners (excluding surgical procedures); carbamazepine monitoring for hyponatremia and agranulocytosis; FDA-approved medications for opioid use disorder maintenance (methadone, buprenorphine, and naltrexone); essential components of emergency psychiatric evaluation including psychosis assessment, suicide and homicide risk, and ruling out organic causes; and the honeymoon phase in the cycle of domestic violence characterized by apologies, promises, and affection following acute battering. Each question is accompanied by a detailed rationale explaining the clinical reasoning, evidence-based guidelines, ethical principles, legal standards, and pharmacologic mechanisms, making this resource ideal for psychiatric-mental health nurse practitioner students preparing for final examinations, certification, and clinical practice across the lifespan.